Senores Pharmaceuticals Limited (BOM:544319)
India · Delayed Price · Currency is INR 1,387.20
+64.50 (4.88%)
At close: Oct 6, 2026
Senores Pharmaceuticals Market Cap
Senores Pharmaceuticals has a market cap or net worth of 63.95 billion as of October 7, 2026. Its market cap has increased by 90.69% in one year.
Market Cap
63.95B
Enterprise Value
66.08B
Revenue
6.80B
Global Rank
n/a
Country Rank
n/a
PE Ratio
50.21
ChartMarket Cap Chart
Since December 30, 2024, Senores Pharmaceuticals's market cap has increased from 25.65B to 63.95B, an increase of 149.28%. That is a compound annual growth rate of 67.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 63.95B | 68.89% |
| Dec 31, 2025 | 37.87B | 44.60% |
| Dec 31, 2024 | 26.19B | 2.07% |
| Dec 30, 2024 | 25.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Viyash Scientific | 101.17B |
| Procter & Gamble Health | 89.04B |
| Morepen Laboratories | 73.26B |
| Bliss GVS Pharma | 72.75B |
| Sanofi India | 69.82B |
| FDC Limited | 54.63B |
| Evonile Pharma | 48.59B |
| Gufic Biosciences | 41.94B |